Dr. Ellen Amy Overson, MD

Dr. Overson practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Overson's NPI, 1770903429, was assigned on April 21, 2014. Dr. Overson graduated from David Geffen School of Medicine at UCLA in 2002. Dr. Overson holds Minnesota license 60094.

Dr. Overson's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Overson's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. The medical group on file is Fairview Health Services. Dmand AI also links Dr. Overson to 6 more medical groups, 1 dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Overson practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Overson's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Overson is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Overson's licenses on file in 2 states: Minnesota and California.

CMS data shows 183 Medicare services from Dr. Overson across 3 procedure codes in 2024, for 50 Medicare patients. Medicare paid $11,183 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 50 Medicare patients who saw Dr. Overson in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have high blood pressure, and 64% have mood disorders. 48% are also on Medicaid. Their average risk score is 4.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Overson's median patient age at 60, with 59% women.

In 2024, Dr. Overson wrote 16 Medicare Part D claims. 94% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $960 in total drug cost. In 2020, CMS named 108 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Overson for performance year 2024, reported as part of a group. Dr. Overson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Overson from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $26.

Dr. Overson graduated from David Geffen School of Medicine at UCLA in 2002.